Mydecine Innovations Group, or simply Mydecine, is an American and Canadian pharmaceutical company that is developing psychedelics and entactogens as medicines.[2]
In August 2022, it was reported that Mydecine was experiencing financial difficulties and might cease operations.[2][3] However, the company was able to obtain more funding and did not shutdown.[2] Mydecine made the first legal import of magic mushrooms into Canada in 2021.[4][5]
Mydecine's drug candidates include the psychedelics